These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4262824)

  • 41. The neurotoxicity of the halogenated hydroxyquinolines. A commentary.
    Oakley GP
    JAMA; 1973 Jul; 225(4):395-7. PubMed ID: 4270059
    [No Abstract]   [Full Text] [Related]  

  • 42. [Optic neuritis caused by clioquinol derivatives in children (apropos of 2 cases)].
    Aron JJ; Lebuisson DA; Guidi M
    Bull Soc Ophtalmol Fr; 1977 Apr; 77(4):409-11. PubMed ID: 147140
    [No Abstract]   [Full Text] [Related]  

  • 43. [The history of quinolines].
    Wolffers I
    Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1246-9. PubMed ID: 3160957
    [No Abstract]   [Full Text] [Related]  

  • 44. Halogenated oxyquinoline derivatives and neurological syndromes.
    Shimada Y; Tsuji T; Igata A; Steinitz H
    Lancet; 1971 Jul; 2(7714):41-3. PubMed ID: 4103679
    [No Abstract]   [Full Text] [Related]  

  • 45. [Further study on the neurotoxicity of clioquinol in beagle dogs (author's transl)].
    Tateishi J; Kuroda S; Ikeda H
    Seishin Shinkeigaku Zasshi; 1975 May; 77(5):378-82. PubMed ID: 144926
    [No Abstract]   [Full Text] [Related]  

  • 46. Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-.
    Shigematsu I
    Jpn J Med Sci Biol; 1975; 28 Suppl():35-55. PubMed ID: 136540
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bilateral optic atrophy in a one and one-half-year-old child possibly a result of administration of iodochlorhydroxyquinoline (Enterovioform)].
    Drukker J; Lindenburg PA
    Ned Tijdschr Geneeskd; 1972 Sep; 116(36):1618-20. PubMed ID: 4262826
    [No Abstract]   [Full Text] [Related]  

  • 48. Chinese acupuncture treatment for SMON patients.
    Katahira K; Kobayshi T; Higashida T; Kamae S; Nakajima Y; Fujimoto S
    Chin Med J (Engl); 1986 Nov; 99(11):910-1. PubMed ID: 2953563
    [No Abstract]   [Full Text] [Related]  

  • 49. The aetiology of SMON may involve an interaction between clioquinol and environmental metals.
    Tjälve H
    Med Hypotheses; 1984 Nov; 15(3):293-9. PubMed ID: 6240588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Notes on neuropathies appearing during treatments with clioquinol].
    Schoeller JP
    Therapie; 1973; 28(2):401-4. PubMed ID: 4358277
    [No Abstract]   [Full Text] [Related]  

  • 51. [Case of subacute myelo-optico-neuropathy].
    Mackiewicz J; Wendorff J
    Neurol Neurochir Pol; 1980; 14(1):121-3. PubMed ID: 6445513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [SMON--a model of the iatrogenic disease].
    Takasu T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):866-9. PubMed ID: 15152488
    [TBL] [Abstract][Full Text] [Related]  

  • 53. S.M.O.N.: different effects of dichloroquine and iodochloroquine in cats and mice.
    Zeiller P; Sensch KH; Dahme E
    Lancet; 1973 Jan; 1(7793):44. PubMed ID: 4118568
    [No Abstract]   [Full Text] [Related]  

  • 54. Clioquinol.
    Bernard G; Griffith RW
    Lancet; 1977 Apr; 1(8018):956. PubMed ID: 67419
    [No Abstract]   [Full Text] [Related]  

  • 55. Iatrogenic causes of neurologic disorders: part 1. Affect, convulsions, and encephalopathies.
    Buchanan DS
    Geriatrics; 1978 Aug; 33(8):59-64. PubMed ID: 149697
    [No Abstract]   [Full Text] [Related]  

  • 56. [Contribution of Japanese researchers to progress in the field of neurology in the last 100 years: SMON].
    Igata A
    Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2302-3. PubMed ID: 12373837
    [No Abstract]   [Full Text] [Related]  

  • 57. Experimental reproduction of SMON in animals by prolonged administration of clioquinol: clinico-pathological findings.
    Tateishi J; Otsuki S
    Jpn J Med Sci Biol; 1975; 28 Suppl():165-86. PubMed ID: 136536
    [No Abstract]   [Full Text] [Related]  

  • 58. [SMON syndrome].
    Igata A
    Nihon Rinsho; 1977; 35 Suppl 1():626-7. PubMed ID: 148526
    [No Abstract]   [Full Text] [Related]  

  • 59. Oxyquinoline toxicity.
    Soffer M; Basdevant A; Sarragoussi JJ; Raison J; Guy-Grand B
    Lancet; 1983 Mar; 1(8326 Pt 1):709. PubMed ID: 6132067
    [No Abstract]   [Full Text] [Related]  

  • 60. [Subacute neuromyelitis with optic neuritis following chloroiodoquine. A new case].
    Vitale C; Feldman JL; Hubault A; Weisbecker J; Bechetoille A; de Sèze S
    Ann Med Interne (Paris); 1974 Dec; 125(12):941-4. PubMed ID: 4283405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.